Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122726
Filing Date
2024-11-07
Accepted
2024-11-07 06:03:27
Documents
106
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tbio-20240930.htm   iXBRL 10-Q 3190963
2 EX-10.1 tbio-ex10_1.htm EX-10.1 101423
3 EX-10.2 tbio-ex10_2.htm EX-10.2 28190
4 PDF COURTESY COPY tbio-ex10_2.pdf EX-10.2 134381
5 EX-31.1 tbio-ex31_1.htm EX-31.1 14498
6 EX-31.2 tbio-ex31_2.htm EX-31.2 14663
7 EX-32.1 tbio-ex32_1.htm EX-32.1 8676
8 EX-32.2 tbio-ex32_2.htm EX-32.2 8702
9 GRAPHIC img126940177_0.jpg GRAPHIC 60589
  Complete submission text file 0000950170-24-122726.txt   13432062

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tbio-20240930.xsd EX-101.SCH 1936343
109 EXTRACTED XBRL INSTANCE DOCUMENT tbio-20240930_htm.xml XML 2235290
Mailing Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121
Business Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

EIN.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40497 | Film No.: 241432867
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)